{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreibgqegs77eqm3s7hbzoe3e2nvlgzyzcjzyvkt73szqpfuzzu6bu5e",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mg4me47xqcf2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiclqdoeg7ks6ycxd4kegtmo3gy7ypgbxlmrtc6dbycswml3k5sdde"
    },
    "mimeType": "image/jpeg",
    "size": 560418
  },
  "path": "/news/2026-03-fda-black-hormone-treatments-women.html",
  "publishedAt": "2026-03-02T19:40:01.000Z",
  "site": "https://medicalxpress.com",
  "tags": [
    "Health informatics"
  ],
  "textContent": "For years, Cathleen \"Cat\" Brown, a Philadelphia obstetrician and gynecologist, would listen to patients complaining of hot flashes, brain fog, and painful sex and prescribe estrogen as a safe option for easing their menopausal symptoms. But when the women read the drug label and pharmacy package insert, they'd recoil at a \"black box\" warning, Brown said. The bold, black-bordered alert warned women that estrogen may put them at higher risk of breast cancer, cardiovascular disease, stroke, and dementia.",
  "title": "FDA is removing the 'black box' warning on hormone treatments for women in menopause"
}